AKE 0.00% $9.83 allkem limited

Advantage Lithium Junior Partner, page-3

  1. 431 Posts.
    lightbulb Created with Sketch. 60
    I hold both companies. Even though I also get inpatient, I do not think that Advantage’s exploratory reports will necessarily help its SP that much. What should make a major difference should be the resource estimate, the financing/final agreement with Orocobre (hopefully) and the final plans for construction/production. I have a larger investment in Orocobre and a smaller one in Advantage. I am confident that both companies will pay off and I am willing to wait.
 
watchlist Created with Sketch. Add AKE (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.